-
Mashup Score: 1
This is what happens when your boss discovers an online meme generator.
Source: The Medical RepublicCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Research provides an insight into the genetic mechanisms underpinning response to adalimumab in RA, though blood biomarkers remain elusive.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Blood biomarkers to predict TNFi response in RA remain elusive - story by @clarewhatson https://t.co/2mKDVHVEU7
-
-
Mashup Score: 0ARA 2021 | Australian Rheumatology Association - 4 year(s) ago
What a year it has been! Starved of collegial interaction due to Covid? The Organising Committee of the Australian Rheumatology Association (ARA) Annual Scientific Meeting invites you to join us for a Hybrid Virtual Meeting with various Satellite Hub locations. This will be a shorter format meeting and will be held over only 3 days from 21-23 May, 2021. Sydney, Australia will host the main hybrid…
Categories: Latest Headlines, RheumatologyTweet-
We've booked our tickets to the ARA Annual Scientific Meeting - can't wait! https://t.co/hayexqkmFi @AusRheum @frogsandstars @KarinaBray7
-
-
Mashup Score: 0Filgo and friends in RA: the choice is too damn high - Rheuma - 4 year(s) ago
The tyranny of choice has crippled Jyseleca and other potentially useful drugs, but there are plenty of opportunities left in rheumatology drug development.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Despite recent set-backs for JAK inhibitors, there are still plenty of opportunities in rheuma drug development - and @drdavidliew has some ideas! https://t.co/GVsUOT0QHq
-
-
Mashup Score: 0What now for JAK inhibitors? - Rheuma - 4 year(s) ago
JAK inhibitors have recently hit safety-related stumbling blocks, but commercial decisions are also at play in Jyseleca’s withdrawal from RA markets.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
What now for anti-JAKs? @BFalkenmire looks at the impact of recent safety issues and market realities on these potentially useful drugs in the RA armamentarium. https://t.co/56Ke9H0bmG
-
-
Mashup Score: 0Concerns telehealth will remain undersubsidised - Rheuma - 4 year(s) ago
Rheumatologists want support for the hidden costs of telehealth delivery as government delays making permanent arrangements.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
“The bottom line is I can only see half as many patients with Zoom than I could face-to-face." - rheumatologist lament telehealth limitations. @BFalkenmire reports for @RheumaRepublic https://t.co/EnbQMGmNmz
-
-
Mashup Score: 0
In a surprise move, biopharmaceutical company Gilead Sciences has withdrawn its TGA application for filgotinib (Jyseleca) for use in Australia.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Gilead pulls plug on filgotinib for Australian RA patients https://t.co/kpIoEbs5qW
-
-
Mashup Score: 0How many people have died from COVID-19? - Rheuma - 5 year(s) ago
Cause of death is never as simple as it sounds and SARS-CoV-2 makes it even less straightforward.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
How many people have died from COVID-19?- deep dive by @BiancaNogrady https://t.co/mqtyUbZ7jL
-
-
Mashup Score: 0Vagus nerve stimulation for RA symptom control - Rheuma - 5 year(s) ago
A small study presented at ACR showed potential for non-invasive vagus nerve stimulation treatment of drug-refractory RA patients.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Vagus nerve stimulation has long been used to treat epilepsy and depression. Attention is now on other conditions, including potential treatment of autoimmune and inflammatory diseases - story by @KarinaBray7 https://t.co/NfFF2Arqia
-
-
Mashup Score: 158Love (and sex) in the time of COVID-19 - Rheuma - 5 year(s) ago
How has the pandemic changed dating and relationships?
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Love (and sex) in the time of COVID-19 by @LJ_Hales https://t.co/TZCiUcbaPO
-
RT @Medicalrepublic: Happy memeday! https://t.co/Ut9709hNRb https://t.co/UioozUMwgo